The London Company, an investment management company, released “The London Company Small Cap Strategy” first quarter 2024 investor letter. A copy of the letter can be downloaded here. In the quarter, the fund gained 8.3% (8.2%, net) compared to a 5.2% increase in the Russell 2000 Index. Stock selection led the portfolio to outperform in the quarter, partially offset by sector exposure. In addition, you can check the top 5 holdings of the fund to know its best picks in 2024.
The London Company Small Cap Strategy featured stocks like Certara, Inc. (NASDAQ:CERT) in the first quarter 2023 investor letter. Headquartered in Princeton, New Jersey, Certara, Inc. (NASDAQ:CERT) is a software product and technology-enabled services provider for bio-simulation. On May 3, 2024, Certara, Inc. (NASDAQ:CERT) stock closed at $17.60 per share. One-month return of Certara, Inc. (NASDAQ:CERT) was -7.07%, and its shares lost 24.85% of their value over the last 52 weeks. Certara, Inc. (NASDAQ:CERT) has a market capitalization of $2.819 billion.
The London Company Small Cap Strategy stated the following regarding Certara, Inc. (NASDAQ:CERT) in its first quarter 2024 investor letter:
“Initiated: Certara, Inc. (NASDAQ:CERT) – CERT is the global leader in biosimulation technology, providing software and science- based services to big pharma, biotechs, and regulatory bodies. CERT runs an attractive software and services model that generates high-margin recurring revenues. Over 50% of revenues come from blue-chip customers, including 39 of the top 40 biopharma companies in the world. CERT’s flagship platform, Simcyp, is the gold standard in the industry, and disruption risk is low. CERT is poised to benefit from the mid-teens% growth projected for the biosimulation market CERT boasts a strong balance sheet and impressive cash flow generation.”
25 States with the Lowest Life Expectancy in the US
Certara, Inc. (NASDAQ:CERT) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 12 hedge fund portfolios held Certara, Inc. (NASDAQ:CERT) at the end of the fourth quarter which was 13 in the previous quarter.
We previously discussed Certara, Inc. (NASDAQ:CERT) in another article, where we shared the list of top medical AI companies. In addition, please check out our hedge fund investor letters Q1 2024 page for more investor letters from hedge funds and other leading investors.
Suggested Articles:
- 15 States with the Most Colleges in the US
- Morgan Stanley’s Top 15 Stock Picks for 2024
- 14 Best Financial Sector Dividend Stocks To Invest In
Disclosure: None. This article is originally published at Insider Monkey.
